Ally Financial’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,000
Closed -$1.03M 127
2025
Q4
$1.03M Buy
+13,000
New +$1.02M 0.13% 102
2020
Q1
Sell
-30,000
Closed -$2.06M 129
2019
Q4
$2.06M Buy
+30,000
New +$2.05M 0.34% 81
2019
Q2
Sell
-50,000
Closed -$3.43M 103
2019
Q1
$3.43M Hold
50,000
0.65% 51
2018
Q4
$2.98M Hold
50,000
0.39% 53
2018
Q3
$3.35M Hold
50,000
0.67% 49
2018
Q2
$3.24M Buy
50,000
+15,000
+43% +$981K 0.64% 51
2018
Q1
$2.51M Buy
35,000
+20,000
+133% +$1.44M 0.38% 74
2017
Q4
$1.13M Buy
+15,000
New +$1.1M 0.22% 92
2017
Q1
Sell
-20,000
Closed -$1.31M 105
2016
Q4
$1.31M Buy
+20,000
New +$1.37M 0.22% 89
2015
Q4
Sell
-80,000
Closed -$5.08M 128
2015
Q3
$5.08M Hold
80,000
0.52% 46
2015
Q2
$5.23M Hold
80,000
0.53% 47
2015
Q1
$5.55M Hold
80,000
0.57% 52
2014
Q4
$5.54M Hold
80,000
0.61% 52
2014
Q3
$5.22M Hold
80,000
0.72% 47
2014
Q2
$5.45M Hold
80,000
0.64% 56
2014
Q1
$5.19M Buy
+80,000
New +$5.04M 0.55% 68
2013
Q3
Sell
-135,000
Closed -$7.73M 120
2013
Q2
$7.73M Buy
+135,000
New +$8.01M 0.76% 48

Other funds holding CL

Ally Financial's CL Position: Q1 2026 in Review

Ally Financial sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 13,000 shares — an estimated $1.03M sold.

Ally Financial first reported a position in CL in Q2 2013 and held it in 17 quarters. The position peaked at $7.73M in Q2 2013. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Ally Financial reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Ally Financial sold 13,000 Colgate-Palmolive shares in Q1 2026, an estimated $1.03M.
  • Ally Financial first reported a position in Colgate-Palmolive in Q2 2013 and held it in 17 quarters.
  • Ally Financial's Colgate-Palmolive position peaked at $7.73M in Q2 2013.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Ally Financial's 13F filing for Q1 2026, filed 12 May 2026.